The global metabolism assay market is foreseen to witness a CAGR of 8.1% during the forecast period. The market is expected to rise from US$ 1.7 billion in 2024 to US$ 3.6 billion by 2034.
The escalating prevalence of metabolic disorders like diabetes, obesity, and cardiovascular diseases propels this expansion. Concurrently, the uptake of personalized medicine and targeted therapies, facilitated by metabolism assays offering individualized metabolic profiles, is amplifying market demand.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-19265
Advancements in metabolic genetics and pharmacogenomics are driving extensive research activities, thereby bolstering the adoption of metabolism assays across various healthcare sectors. The burgeoning market is also fueled by the expansion of metabolic drugs, necessitating rigorous metabolic screening for efficacy and safety assessment. Technological innovations, particularly in cellular metabolism assays, such as high-throughput screening and real-time monitoring.
Increased investments in healthcare infrastructure and research facilities by developing and developed economies are creating a conducive environment for the expansion of metabolic testing capabilities. Expanding the biopharmaceutical industry and increasing investments in healthcare infrastructure are expected to fuel market growth in the coming years.
“Advancements in technologies like high-throughput screening and metabolomics are revolutionizing metabolic profiling, offering robust tools for drug discovery and development. The expanding biopharmaceutical industry and rising investments in healthcare infrastructure are expected to fuel market growth in the coming years,” says an analyst at FMI.
Key Takeaways from the Market Study:
- Sales of assay kits and reagents are increasing at a 7.8 % CAGR through 2034.
- Hospitals as end users are rising in the metabolism assay market at a 7.6% CAGR from 2024 to 2034.
- The metabolism assay market in South Korea has the potential to increase at a CAGR of 10.0% through 2034.
- The metabolism assay market in Japan is projected to inflate at a CAGR of 9.9% through 2034.
- The metabolism assay market in the United Kingdom is predicted to rise at a 9.2% CAGR through 2034.
- The metabolism assay market in China is anticipated to develop at a CAGR of 8.9% through 2034.
- The metabolism assay market in the United States is estimated to rise at an 8.4% CAGR through 2034.
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-19265
Competitive Landscape:
Major companies such as Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation, and PerkinElmer are actively expanding the metabolism assay market by investing in research and development to enhance assay accuracy, sensitivity, and throughput. Strategic collaborations with academic institutions and pharmaceutical companies are upsurging the market growth by facilitating the development of novel assays tailored to specific metabolic pathways and drug targets.
Recent Developments:
- Genefitletics launched ORAHYG, an at-home oral microbiome functional activity test in New Delhi, on Nov 27, 2023.
- Cipla launched Cippoint, a point-of-care testing device, on Jan 18, 2023, which caters to various testing parameters.
- CN Bio extended its services on Nov 06, 2020, offering drug metabolism and safety toxicity testing using predictive 3D Liver-on-Chip technology.
Market Segmentation:
By Product Type:
- Assay Kits and Reagents
- Instruments and Analyzers
By Instruments and Analyzers:
- Diagnostics
- Diabetes
- Obesity
- Cancer
- Cardiovascular Diseases
- Other diagnostic applications
- Research
By Technology:
- Colorimetry
- Fluorimetry
- Spectrometry
By End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biopharmaceutical Companies
- Other End-Users
By Region:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa (MEA)
- Europe
Request Purchase on Report: https://www.futuremarketinsights.com/checkout/19265
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
